Marshall Wace North America’s Braskem BAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$384K Buy
+17,616
New +$407K ﹤0.01% 1178
2020
Q2
Sell
-2,700
Closed -$18K 1162
2020
Q1
$18K Buy
+2,700
New +$34.4K ﹤0.01% 1141
2019
Q2
Sell
-500
Closed -$13K 1158
2019
Q1
$13K Sell
500
-6,785
-93% -$188K ﹤0.01% 1433
2018
Q4
$178K Sell
7,285
-4,001
-35% -$109K ﹤0.01% 976
2018
Q3
$326K Sell
11,286
-146,056
-93% -$4.15M ﹤0.01% 774
2018
Q2
$4.09M Buy
157,342
+138,501
+735% +$3.58M 0.02% 568
2018
Q1
$546K Buy
+18,841
New +$549K ﹤0.01% 1134
2017
Q4
Sell
-198,023
Closed -$5.35M 1369
2017
Q3
$5.35M Buy
+198,023
New +$4.86M 0.03% 528

Other funds holding BAK

Marshall Wace North America's BAK Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Braskem (BAK) in Q3 2021: 17,616 shares worth $384K. The stake represents ﹤0.01% of the portfolio and ranks #1178 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in BAK as recently as Q1 2020.

Marshall Wace North America first reported a position in BAK in Q3 2017 and has held it in 8 quarters since. The position peaked at $5.35M in Q3 2017. 43 funds tracked by Wall St. Rank hold BAK as of Q3 2021.

  • Marshall Wace North America held 17,616 shares of Braskem worth $384K as of Q3 2021.
  • Braskem was a new Marshall Wace North America position in Q3 2021.
  • Braskem made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1178 holding.
  • Marshall Wace North America first reported a position in Braskem in Q3 2017 and has held it in 8 quarters since.
  • Marshall Wace North America's Braskem position peaked at $5.35M in Q3 2017.
  • 43 funds tracked by Wall St. Rank held Braskem as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.